Finzati - Logo
MBRX logo

Moleculin Biotech, Inc.

MBRX • Biotechnology
$0.71
▲ +0.03 (+5.09%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.05M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.02Healthy liquidity · 1.41Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:41 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.71
Change5.09%
Market Cap$3.05M
52W Range0.16 - 17.23
Beta1.83
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio1.41
Quick Ratio1.41
Volume1.31M

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.02Healthy liquidity · 1.41Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/2/2016
Industry: Biotechnology
P/B i: 0.26
Debt / Equity i: 0.02
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.02
Current Ratio: 1.41
Quick Ratio: 1.41
Status: Good

Insider Transactions

Recent executive and insider activity

PICKER DONALD H
Transaction: 08/03/2026
BUY
Change
+173,333
Price
$0.75
Filing
08/05/2026
Type
BUY
PICKER DONALD H
Transaction: 08/03/2026
BUY
Change
+519,999
Price
Not reported
Filing
08/05/2026
Type
BUY
KLEMP WALTER V
Transaction: 08/03/2026
BUY
Change
+533,333
Price
$0.75
Filing
08/05/2026
Type
BUY